162 related articles for article (PubMed ID: 17109104)
1. Matrix metalloproteinases in rectal mucosa, tumour and plasma: response after preoperative irradiation.
Angenete E; Langenskiöld M; Falk P; Ivarsson ML
Int J Colorectal Dis; 2007 Jun; 22(6):667-74. PubMed ID: 17109104
[TBL] [Abstract][Full Text] [Related]
2. Preoperative radiotherapy and extracellular matrix remodeling in rectal mucosa and tumour matrix metalloproteinases and plasminogen components.
Angenete E; Oresland T; Falk P; Breimer M; Hultborn R; Ivarsson ML
Acta Oncol; 2009; 48(8):1144-51. PubMed ID: 19863222
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta-1 in rectal tumour, mucosa and plasma in relation to radiotherapy and clinical outcome in rectal cancer patients.
Angenete E; Langenskiöld M; Palmgren I; Falk P; Oresland T; Ivarsson ML
Int J Colorectal Dis; 2007 Nov; 22(11):1331-8. PubMed ID: 17657504
[TBL] [Abstract][Full Text] [Related]
4. Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer.
Kumar A; Collins HM; Scholefield JH; Watson SA
Br J Cancer; 2000 Feb; 82(4):960-5. PubMed ID: 10732772
[TBL] [Abstract][Full Text] [Related]
5. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy.
Unsal Kilic D; Uner A; Akyurek N; Erpolat P; Dursun A; Pak Y
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):196-203. PubMed ID: 17071013
[TBL] [Abstract][Full Text] [Related]
8. Radiation induced MMP expression from rectal cancer is short lived but contributes to in vitro invasion.
Speake WJ; Dean RA; Kumar A; Morris TM; Scholefield JH; Watson SA
Eur J Surg Oncol; 2005 Oct; 31(8):869-74. PubMed ID: 16081236
[TBL] [Abstract][Full Text] [Related]
9. Circulating gelatinases are not prognostic of treatment response and survival in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy.
Ulger S; Kilic D; Demircioglu F; Demirtas CY; Pasaoglu OT
J Cancer Res Ther; 2018; 14(Supplement):S90-S96. PubMed ID: 29578156
[TBL] [Abstract][Full Text] [Related]
10. The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis.
Fuksiewicz M; Kotowicz B; Rutkowski A; Kowalska M
Tumour Biol; 2015 May; 36(5):3629-35. PubMed ID: 25549795
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
Schwandner O; Schlamp A; Broll R; Bruch HP
Int J Colorectal Dis; 2007 Feb; 22(2):127-36. PubMed ID: 16896992
[TBL] [Abstract][Full Text] [Related]
12. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
Lorenzl S; Buerger K; Hampel H; Beal MF
Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
14. The matrix metalloproteinase system in oral squamous cell carcinoma.
Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
Br J Oral Maxillofac Surg; 2006 Dec; 44(6):482-6. PubMed ID: 16338034
[TBL] [Abstract][Full Text] [Related]
15. Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology.
Thrailkill KM; Moreau CS; Cockrell G; Simpson P; Goel R; North P; Fowlkes JL; Bunn RC
Clin Chem Lab Med; 2005; 43(12):1392-9. PubMed ID: 16309379
[TBL] [Abstract][Full Text] [Related]
16. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer.
Langenskiöld M; Holmdahl L; Falk P; Ivarsson ML
Int J Colorectal Dis; 2005 May; 20(3):245-52. PubMed ID: 15592677
[TBL] [Abstract][Full Text] [Related]
18. Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients.
Tutton MG; George ML; Eccles SA; Burton S; Swift RI; Abulafi AM
Int J Cancer; 2003 Nov; 107(4):541-50. PubMed ID: 14520690
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
Baker EA; Bergin FG; Leaper DJ
Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431
[TBL] [Abstract][Full Text] [Related]
20. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
